Teams | University of Pennsylvania Prevention Research Center

Teams

Leadership

Karen Glanz, PhD, MPH, PRC Director

Kevin Volpp, MD, PhD, PRC Director

PRC Core Leadership

Community Engagement, Partnerships, & Technical Assistance

David Grande, MD, MPA, Core Co-Lead

Carolyn Cannuscio, ScD, Core Co-Lead

Communication & Dissemination

Training

Douglas Wiebe, PhD, Core Lead

Evaluation

John Holmes, PhD, Core Co-Lead

Internal Advisory Board

Jennifer Pinto-Martin, PhD, MPH, Chair; Internal Advisory Board

Chyke Doubeni, MD, FRCS, MPH, Internal Advisory Board

Frances Barg, PhD, MEd, Internal Advisory Board; Philadelphia Health Leadership Institute

Joseph Cappella, PhD, Internal Advisory Board

Jerry C. Johnson, MD, Internal Advisory Board

Ron Keren, MD, MPH, Internal Advisory Board

Daniel Polsky, PhD, Co-Investigator; The Healthy Weigh Study, Internal Advisory Board Member

Community Advisory Board

Glenn Bryan, MSW, Community Advisory Board

Natalie Levkovich, Community Advisory Board

Allison Karpyn, PhD, Community Advisory Board

Bill McKinney, PhD, Community Advisory Board

Carol Rogers, PA, Community Advisory Board

Q & A Spotlight

Andrew Strasser, PhD, Co-Investigator; Skin Cancer Communication Project
Are reduced nicotine content cigarettes less harmful for smokers?
Nicotine is addictive; as long as there's a sufficient amount of nicotine in the cigarette to sustain addiction, it's not less harmful. And, reduced nicotine does not mean reduced toxins. There are over 4000 compounds in cigarettes; 81 of which are known carcinogens and others that contribute to smoking-related diseases. What our research shows is that the amount of nicotine reduction in the cigarette affects behavior and exposure. Identifying a nicotine threshold, however, requires more research.